- Home
- TZOO vs NBTX Comparison
TZOO vs NBTX Comparison
Compare TZOO & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TZOO
- NBTX
- Stock Information
- Founded
- TZOO 1998
- NBTX 2003
- Country
- TZOO United States
- NBTX France
- Employees
- TZOO N/A
- NBTX N/A
- Industry
- TZOO Advertising
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- TZOO Consumer Discretionary
- NBTX Health Care
- Exchange
- TZOO Nasdaq
- NBTX Nasdaq
- Market Cap
- TZOO 166.1M
- NBTX 178.7M
- IPO Year
- TZOO 2002
- NBTX 2020
- Fundamental
- Price
- TZOO $14.66
- NBTX $3.41
- Analyst Decision
- TZOO Strong Buy
- NBTX Strong Buy
- Analyst Count
- TZOO 4
- NBTX 1
- Target Price
- TZOO $23.00
- NBTX $8.00
- AVG Volume (30 Days)
- TZOO 151.9K
- NBTX 7.6K
- Earning Date
- TZOO 04-29-2025
- NBTX 04-02-2025
- Dividend Yield
- TZOO N/A
- NBTX N/A
- EPS Growth
- TZOO 10.54
- NBTX N/A
- EPS
- TZOO 1.00
- NBTX N/A
- Revenue
- TZOO $85,057,000.00
- NBTX N/A
- Revenue This Year
- TZOO $16.43
- NBTX N/A
- Revenue Next Year
- TZOO $25.78
- NBTX $221.06
- P/E Ratio
- TZOO $14.71
- NBTX N/A
- Revenue Growth
- TZOO 0.23
- NBTX N/A
- 52 Week Low
- TZOO $7.12
- NBTX $2.76
- 52 Week High
- TZOO $24.85
- NBTX $7.51
- Technical
- Relative Strength Index (RSI)
- TZOO 55.70
- NBTX 52.75
- Support Level
- TZOO $13.22
- NBTX $3.26
- Resistance Level
- TZOO $15.08
- NBTX $3.65
- Average True Range (ATR)
- TZOO 1.24
- NBTX 0.19
- MACD
- TZOO 0.20
- NBTX 0.02
- Stochastic Oscillator
- TZOO 59.14
- NBTX 35.00
About TZOO Travelzoo
Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; and Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties. Most of the company's revenue is derived from North America.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.